Clinical Trial Manager at Enterprise
High Conscientiousness and Extraversion to coordinate investigative sites, ensure data integrity, and meet GCP deadlines in clinical studies.
In enterprise pharma, multi-market regulatory complexity is the norm
10-15 year development cycles require genuine long-term vision
Pharmacovigilance and patient safety are non-delegable responsibilities
Ideal OCEAN+ Profile
At enterprise companies (201-1000 employees), ability to solve complex recruitment problems, adapt protocols, and propose creative solutions to site deviations
At enterprise companies (201-1000 employees), rigor in following GCP, managing data queries, site monitoring, and meeting regulatory reporting deadlines
At enterprise companies (201-1000 employees), coordination of site teams, CROs, monitors, and sponsors; status presentations to medical and regulatory leadership
At enterprise companies (201-1000 employees), managing relationships with investigators, site coordinators, and CROs while maintaining authority over the protocol and data quality
At enterprise companies (201-1000 employees), tolerance for the stress of regulatory deadlines, slow recruitment, patient retention issues, and critical protocol deviations
At enterprise companies (201-1000 employees), the Clinical Trial Manager operates under GCP with defined monitoring protocols, scheduled follow-up visits, and deviation-reporting procedures to the CRO and regulatory agency; adherence to the monitoring process is what protects the integrity of the trial data
Strengths and Red Flags
Strengths
- Coordinating multiple investigative sites while maintaining data integrity and quality
- Managing patient recruitment and retention to meet study deadlines
- Managing product portfolios across multiple development and commercialization phases
- Robust regulatory compliance with FDA, EMA, and local health authorities
Red Flags
- Lax data management leading to queries and integrity issues found in audits
- Late reporting of recruitment problems that prevents timely corrective action
- Paralysis in the face of complex multi-product, multi-phase portfolios
- Internal bureaucracy that delays go/no-go pipeline decisions
Interview Questions
How many sites did you coordinate simultaneously in your most complex study? How did you organize monitoring, and what were your criteria for escalating a site issue?
Evaluates: Conscientiousness and management of multi-site complexity
Describe a situation where a study's recruitment was well below plan. What actions did you take and what was the result?
Evaluates: Openness and resilience under high-impact operational problems
How did you manage a multi-product portfolio across different development phases?
Evaluates: Systemic vision and prioritization capacity at scale
How did you coordinate a multi-market regulatory registration process?
Evaluates: Conscientiousness and coordination in highly complex environments
More about Clinical Trial Manager
Career path, personality archetypes and similar roles in the full profile.
This Role in Other Contexts
Clinical Trial Manager — base profile with no company context
View profile → Startup (1-50 employees)In pharma startups, time to regulatory approval defines survival
View profile → SMB (51-200 employees)In SMB pharma, quality and compliance are the license to operate
View profile → Global (1001+ employees)Global pharma means registrations in dozens of markets with different requirements
View profile →Does your next Clinical Trial Manager at Enterprise (201-1000 employees) match this profile?
Map anyone's OCEAN+ profile with the Talent Diagnostic: free, no signup, 10 minutes.
20 statements · 10 minutes · no card